000739:SHE
Apeloa Pharmaceutical Co Ltd
23,42Â CNY
arrow_downward
−1,64%(−0,39) 1 d
16 okt., 15:04:48 GMT+8 · CNY
search
Alla symboler
| Symbol | Pris | Ändring | Ändring i procent |
|---|
insights_autoGenererar de viktigaste insikterna för 000739 …
Öppen
24,04Â CNY
Högt
24,76Â CNY
LÃ¥gt
23,09Â CNY
Börsvärde
27,13Â md
Genomsn. vol.
16,27Â mn
Volym
15,09Â mn
Utdelning
1,61Â %
Kvartalsvis utdelning
0,09Â CNY
Ex-utdelningsdatum
8 okt. 2026
P/E-tal
31,78
52v högst
28,50Â CNY
52v lägst
14,89Â CNY
EPS
0,74Â CNY
Utestående aktier
1,16Â md
Antal anställda
7Â tn
Öppen
24,04Â CNY
Högt
24,76Â CNY
LÃ¥gt
23,09Â CNY
Börsvärde
27,13Â md
Genomsn. vol.
16,27Â mn
Volym
15,09Â mn
Utdelning
1,61Â %
Kvartalsvis utdelning
0,09Â CNY
Ex-utdelningsdatum
8 okt. 2026
P/E-tal
31,78
52v högst
28,50Â CNY
52v lägst
14,89Â CNY
EPS
0,74Â CNY
Utestående aktier
1,16Â md
Antal anställda
7Â tn
Relaterade aktier
Nyheter och artiklar
Från webbkällor och nyhetspartner
HurBra.se
·
för 2 dagar sedan
USA-börsen 15 oktober 2026: Vård lyfte, AI pressades
Foreign Policy Journal
·
för 19 minuter sedan
SoundHound AI (NASDAQ: SOUN) Leads Automation Software Sector In Q2 Earnings Rankings
Simply Wall Street
·
för 26 minuter sedan
Is Intellia Therapeutics (NTLA) Cheap Or Pricey On Its New Chief Medical Officer Appointment?
Stock Traders Daily
·
för 4 timmar sedan
Discipline and Rules-Based Execution in NANC Response
Profil
Apeloa Pharmaceutical Co., Ltd., known as Apeloa, is a Chinese pharmaceutical manufacturer under Hengdian Group. The company is headquartered in Hengdian, Dongyang, Zhejiang, China. It was founded in 1989 and has been listed on the Shenzhen Stock Exchange since 9 May 1997. Apeloa provides contract development and manufacturing services and manufactures APIs and finished dosage forms; products span cardiovascular, anti-infective, psychiatric and oncology areas.
Apeloa has 7400 employees, 8 manufacturing sites and 3 R&D centers in Boston, Shanghai and Hengdian, covering flow chemistry, synthetic biology and biocatalysis, and peptide development. It has invested over USD20 million in flow chemistry over the past ten years in an effort to advance sustainable pharmaceutical manufacturing. In Boston, its 17,000-square-foot facility does R&D related to chemistry needs in drug development, including preclinical chemistry, scale-up production and new drug development.
Apeloa Pharmaceutical has successfully passed 20 U.S. FDA inspections since 2006. Wikipedia
Om Apeloa Pharmaceutical Co Ltd